|
The document details a study conducted by White Eagle Toxicology Laboratories on the dermal sensitization of a test article identified as H-21891, sponsored by E.I. du Pont de Nemours and Company, using the modified Buehler method in guinea pigs.
|
2003 |
AR226-3055
|
v102z7YBO8X7xZNENEN56vbrY |
87 |
|
The document reports on a study conducted by DuPont to evaluate the influence of the substance H-25134 on the growth and growth rate of the green alga Selenastrum capricornutum, with algae exposed to various concentrations of H-25134 over a 72-hour period.
|
2002 |
AR226-3214
|
v14bJpavYNXBma5jaXyKvv0yZ |
11 |
|
The document details the analytical report for the dosing suspensions of H-24516, a substance used in a pilot developmental toxicity study in rats, focusing on concentration verification and stability analysis at various concentrations.
|
2002 |
AR226-3215
|
y022Z5rgB0d8d6VLav8MwxVX |
18 |
|
The document reports on a bacterial reverse mutation test conducted by BioReliance for E. I. du Pont de Nemours and Company, evaluating the mutagenicity of a test substance related to DuPont Project ID DuPont-5234.
|
2001 |
AR226-3173
|
Z82jLmdr9X7L08VOJkGQbw9Rp |
36 |
|
The document is a final report on an in vitro chromosome aberration test conducted on a substance by E.I. du Pont de Nemours and Company at BioReliance, indicating that the test substance was stable under study conditions.
|
2001 |
AR226-3174
|
2JyBenewEyRXxwZXBO3y8yZoR |
35 |
|
The document reports on a static, acute 48-hour toxicity test of DuPont-6010 (H-24516) on Daphnia magna, revealing that exposure to increasing concentrations of the substance resulted in varying levels of immobility, with 50% immobility observed at the highest concentration of 1000 mg/L.
|
2001 |
AR226-3175
|
nNRy0x2p3z7yqBz42qenpenM1 |
6 |
|
The document reports on a study conducted by E.I. du Pont de Nemours and Company to assess the impact of a test substance (H-24516) on the growth and growth rate of the green alga Selenastrum capricornutum, revealing effects at various concentrations over a 72-hour exposure period.
|
2001 |
AR226-3176
|
OzgjVELe8JJ0ynqkj2Mv2RMkK |
12 |
|
The document reports on a skin irritation test conducted by E. I. du Pont de Nemours and Company on a test substance, evaluating its acute skin irritation potential in rabbits.
|
2001 |
AR226-3177
|
ykBjjz6J1vooq1RYmN7q67v1V |
13 |
|
The document reports on a 96-hour acute toxicity screening test of a perfluorinated compound (H-24616) conducted by DuPont on the fathead minnow (Pimephales promelas), evaluating its effects at various concentrations.
|
2001 |
AR226-3179
|
gDoRnkM0XqRr5ZzB2dgDqYMdG |
5 |
|
The document is an analytical report summarizing the mixing and stability of dosing solutions for a Pilot Developmental Toxicity Study in Rats involving PFOA, confirming that the test substance was mixed properly at the expected concentration of 17%.
|
2001 |
AR226-3178
|
936kvnG33pjkDkwN13R24O2Zq |
13 |
|
The document reports on a developmental toxicity study in rats conducted by E.I. du Pont de Nemours and Company, which assessed the effects of a test substance related to PFOA, confirming its stability and composition during the study while noting some non-compliance with Good Laboratory Practice Standards.
|
2001 |
AR226-3183
|
KJBk9g72Boe555gb6ZOMyxRMw |
149 |
|
This is a DuPont study report (H-24761) detailing a biopersistence screening 10-dose oral gavage study in rats, completed on November 20, 2001, under the direction of Carol Finlay.
|
2001 |
AR226-3190
|
NELmp8Dr3JqYJE76Ky25RR7nV |
83 |
|
The document reports on a static, acute 96-hour toxicity test of the substance DuPont-8838 (a perfluorinated compound) on the fathead minnow, Pimephales promelas, conducted by E.I. du Pont de Nemours and Company, which assessed the effects of various concentrations on the organisms.
|
2001 |
AR226-3191
|
KJk7Xp5GoKR8y6oM1n4y58wdw |
5 |
|
This document is a biopersistence screening study report conducted by E.I. du Pont de Nemours and Company on PFOA, detailing a 10-dose oral gavage study in rats, completed on November 26, 2001.
|
2001 |
AR226-3193
|
b9NEE9r1X9n2180EXYNDj7N0 |
83 |
|
The document is a biopersistence screening study report conducted by DuPont on the effects of a 10-dose oral gavage of a trade secret substance in rats, completed on November 26, 2001.
|
2001 |
AR226-3192
|
O1wL15Ge55QEza40YMV4ngL8X |
84 |
|
The document reports on a subchronic toxicity study conducted by DuPont on rats, evaluating the effects of a perfluorinated compound, with findings indicating various liver lesions at different dosage levels.
|
2001 |
AR226-3185
|
XOQeNwwd83GNVNg1BDO62oJb4 |
314 |
|
The document is a study report by DuPont titled "H-24949: Biopersistence Screening 10-Dose Oral Gavage Study in Rats," which evaluates the biopersistence of a test substance through oral administration in rats, completed on November 26, 2001.
|
2001 |
AR226-3194
|
GmyzDEJL4XeJmB7w208wMv23Y |
83 |
|
The document is a biopersistence screening study report conducted by E.I. du Pont de Nemours and Company on PFOA, detailing a 10-dose oral gavage study in rats, completed on November 26, 2001.
|
2001 |
AR226-3195
|
RjR8a8x31jMNeJXa06rgKb0w8 |
83 |
|
The document reports on a static, acute 48-hour toxicity test of the substance H-25134, conducted by DuPont, which assessed its effects on Daphnia magna, revealing varying concentrations of the substance during the study.
|
2001 |
AR226-3196
|
6QqmbB4R5Y2XY8jZ6Epa2vdd |
5 |
|
The document reports on a subchronic toxicity study conducted by DuPont, indicating minimal inflammation in the liver, chronic progressive nephropathy in the kidneys, and minimal colloid alteration in the thyroid gland in female animals exposed to a test substance, likely related to PFOA or PFOS.
|
2001 |
AR226-3200
|
21700RxoJ1JVEw8rLrRaxnzp |
311 |
|
The document is a supplement report from DuPont detailing a biopersistence screening study of a test substance, likely related to PFOA or PFOS, conducted through a 10-dose oral gavage study in rats, completed in 2001.
|
2001 |
AR226-3206
|
J7bKxQyX4B6D2jd49KjJLekX |
40 |
|
The document reports on the Corrositex In Vitro Test conducted by DuPont on the substance H-25124, concluding that it was not corrosive under the test conditions.
|
2001 |
AR226-3208
|
pr6pJ74MMQmkyaD5mvw5BYdd |
9 |
|
The document is a developmental toxicity study in rats conducted by DuPont (Project ID: DuPont-5991) to assess the effects of a perfluorinated compound, specifically focusing on compliance with good laboratory practices and quality assurance measures.
|
2001 |
AR226-3207
|
pBy12y63rRG2zDo84Qdp4v2LE |
165 |
|
The document reports on a static, acute 96-hour toxicity test conducted by E.I. du Pont de Nemours and Company on the substance H-25134, assessing its effects on the rainbow trout (Oncorhynchus mykiss) at various concentrations.
|
2001 |
AR226-3212
|
b5w6bXb5L8bavOXgVdL1kGe70 |
5 |
|
This is a final report from Covance Laboratories (Study 22900-0-4540ECD) detailing an in vivo rat micronucleus assay conducted between October 18, 2001, and November 19, 2001, for an unspecified sponsor.
|
2001 |
AR226-3226
|
X7Z1j2M3G0nLaeZ6ye1Er8zBg |
31 |
|
The document is a confidential study report conducted by Elf Atochem S.A. on the acute eye irritation effects of a test substance in rabbits, completed on January 27, 2000, at the Centre International de Toxicologie.
|
2000 |
AR226-3144
|
OJk6R6D7jZED2ZmDpJxrMneVQ |
21 |
|
This is a DuPont study report (Project ID DuPont-3823) on a Local Lymph Node Assay (LLNA) completed on April 28, 2000, authored by Gregory S. Ladies, PhD.
|
2000 |
AR226-3147
|
zzzgLx3oJKy0Nk9aZvrBexZY7 |
13 |
|
The document reports on an in vitro mammalian chromosome aberration test conducted on a substance identified as H-24335, for E.I. du Pont de Nemours and Company, using Chinese Hamster Ovary (CHO) cells to evaluate its potential genotoxic effects.
|
2000 |
AR226-3148
|
5kzgQaq7jr3dy56oE09zeqgVJ |
39 |
|
The document reports on an in vitro mammalian chromosome aberration test conducted on Chinese Hamster Ovary (CHO) cells to evaluate the effects of a substance associated with DuPont, specifically under study number DuPont-3871.
|
2000 |
AR226-3149
|
rpG61Yxz3pqx25bLRd73E5qeG |
40 |
|
This is a DuPont study report (Project ID DuPont-4199) detailing a Local Lymph Node Assay (LLNA) conducted by E. I. du Pont de Nemours and Company, with a completion date of May 4, 2000.
|
2000 |
AR226-3150
|
NeZvpdMM7gB1LbVMOGEYB5Kyw |
13 |
|
The document is a biopersistence screening study report conducted by E.I. du Pont de Nemours and Company on an unspecified test substance, likely related to PFOA or PFOS, involving a 10-dose oral gavage study in rats, completed on May 19, 2000.
|
2000 |
AR226-3152
|
OJ8b47vkvXnQMj9rBVXxoVVz1 |
82 |
|
The document is a biopersistence screening study report conducted by DuPont on PFOA in rats, completed on July 27, 2000, and certified by senior research scientists.
|
2000 |
AR226-3155
|
LG7r9EX9MK729NwrYYZ3jzmX |
80 |
|
The document is a biopersistence screening study report conducted by E.I. du Pont de Nemours and Company on an unspecified test substance, likely related to PFOA or PFOS, using a 10-dose oral gavage method in rats, completed on August 3, 2000.
|
2000 |
AR226-3156
|
oDp63b0bYjV23r476kG3Emee7 |
81 |
|
This document is a confidential skin sensitization study report conducted by Elf Atochem SA on a test substance, likely related to perfluorinated compounds, using guinea pigs to assess allergenicity through the maximization method.
|
2000 |
AR226-3158
|
3QdnjD14kEQO9kVmxXbapyvgD |
32 |
|
The document is a biopersistence screening study report conducted by DuPont on an unspecified test substance involving 10-dose oral gavage in rats, completed on August 3, 2000.
|
2000 |
AR226-3157
|
GQDowrGoqvOaYZ9DBGQydxY |
82 |
|
The document is a study report titled "H-23926: Biopersistence Screening 10-Dose Oral Gavage Study in Rats" conducted by DuPont, evaluating the biopersistence of a test substance related to perfluorinated compounds.
|
2000 |
AR226-3159
|
Qk5j0nqn9kvBbYmpYxkNx2wr4 |
81 |
|
The document is a study report titled "H-23925: Biopersistence Screening 10-Dose Oral Gavage Study in Rats" conducted by DuPont, focusing on the biopersistence of a perfluorinated compound, with the study completed on August 29, 2000.
|
2000 |
AR226-3160
|
XQYnxdgxD091wgkVLNExBwqK |
109 |
|
The document is a study report from DuPont titled "H-24042: Biopersistence Screening 10-Dose Oral Gavage Study in Rats," which evaluates the biopersistence of a perfluorinated compound, although the specific substance is not mentioned in the provided text.
|
2000 |
AR226-3161
|
eYo1dZJ7g6bxzbVKRODv3wgE |
83 |
|
The document reports on a 96-hour acute toxicity screening test of the substance H-24159, conducted by E.I. du Pont de Nemours and Company, which assessed its effects on the fathead minnow (Pimephales promelas) and found that the substance was stable during the study.
|
2000 |
AR226-3163
|
O11bq8JJ2kVRwbKvky0Zy0jGw |
5 |
|
This document is a biopersistence screening study report conducted by DuPont on the oral gavage of a substance, likely related to PFOA or PFOS, in rats, completed on August 29, 2000.
|
2000 |
AR226-3162
|
E7L9Ya4Q9J0R3g3qd7b4NERR |
93 |
|
The document is a biopersistence screening study report conducted by DuPont on the effects of a 10-dose oral gavage of a trade secret substance in rats, completed on September 1, 2000.
|
2000 |
AR226-3164
|
O3Zye9j14KQV26mm2pNXYyxrL |
93 |
|
The document reports on a study conducted by E.I. du Pont de Nemours and Company that assessed the acute toxicity of the substance H-24516 (a perfluorinated compound) to fathead minnows (Pimephales promelas), finding 100% mortality at the highest concentration of 1000 mg/L after 96 hours.
|
2000 |
AR226-3167
|
oa7qVXeMzXaDbv67ZDp6V9x3 |
5 |
|
This document is a biopersistence screening study report conducted by DuPont on the effects of a 10-dose oral gavage of a perfluorinated compound in rats, completed on September 5, 2000.
|
2000 |
AR226-3165
|
82q8ZQ0RDVYKowxemG2VnqVey |
93 |
|
This document is a study report from DuPont detailing a biopersistence screening of a test substance conducted through a 10-dose oral gavage study in rats, completed on September 5, 2000.
|
2000 |
AR226-3166
|
baowg539rg510nxwezmrZx6kZ |
93 |
|
The document reports on a study conducted by DuPont assessing the acute toxicity of a substance identified as H-24615 to the fathead minnow (Pimephales promelas), revealing 100% mortality at a concentration of 1000 mg/L after 96 hours of exposure.
|
2000 |
AR226-3169
|
rBp61xZ1rERr3kD4pkvanRY0J |
5 |
|
The document reports a study by DuPont on the effects of the substance H-24616 on the growth and growth rate of the green alga Selenastrum capricornutum, finding an EC50 of 30 mg/L and a NOEC of 100 mg/L, indicating medium concern under TSCA due to its acute toxicity to aquatic organisms.
|
2000 |
AR226-3170
|
Dv9011Ky6aj44K2aOkX8Yg42N |
13 |
|
This document details a skin sensitization study conducted by Elf Atochem SA on a test substance using guinea pigs, following the maximization method of Magnusson and Kligman, with the study completed on December 14, 2000.
|
2000 |
AR226-3172
|
2jBzZJ5LJNoDp0ZaB401geaKr |
32 |
|
The document is a study report conducted by BioReliance for E. I. du Pont de Nemours and Company, detailing a reverse mutation study related to perfluorinated compounds, specifically conducted in compliance with EPA GLP standards.
|
2000 |
AR226-3171
|
jgEa7Z222Jea0jwVrQrrNkopN |
65 |
|
The document details a two-week inhalation toxicity study of a test substance conducted by E.I. du Pont de Nemours and Company on male rats, which complied with U.S. EPA TSCA Good Laboratory Practice Standards, despite some minor deviations that did not affect the study's validity.
|
2000 |
AR226-3168
|
3ejBre0x2zzX2V3Lg8mMLXEzy |
181 |
|
This is a DuPont analytical report (Supplement No. 1 for Study H-24001) detailing a biopersistence screening 10-dose oral gavage study in rats, completed on December 12, 2001.
|
2000 |
AR226-3203
|
RpVDLjoEvyz6Bbb55mZ0yaKJV |
40 |
|
The document is a supplement to a biopersistence screening study conducted by DuPont on the oral gavage of rats, focusing on the evaluation of liver weights as part of the assessment of PFOA.
|
2000 |
AR226-3204
|
5km9oLKjOwQyjN3V2EVr0dqmR |
40 |
|
The document is a supplement report from DuPont detailing a biopersistence screening study of PFOA conducted through a 10-dose oral gavage in rats, completed on December 12, 2001.
|
2000 |
AR226-3205
|
MGrGxyLjO9axbaQeGrJkQZm9L |
40 |
|
The document is a supplement report for a biopersistence screening study on DuPont's test substance (likely PFOA or a related perfluorinated compound) conducted on rats, detailing the study's methodology, results, and conclusions.
|
2000 |
AR226-3209
|
V6EgG6vG7J5JeJJdzeaRjDxw |
40 |
|
This is a DuPont analytical report (Supplement No. 1 for Study H-23925) detailing a biopersistence screening 10-dose oral gavage study in rats, completed by the Haskell Laboratory for Health and Environmental Sciences.
|
2000 |
AR226-3210
|
jYjbeg0Xar0rzganYyK1Y9xZ |
40 |
|
This document is a supplement to a biopersistence screening study on PFOA conducted by DuPont, detailing the methodology and findings from a 10-dose oral gavage study in rats, completed in 2001.
|
2000 |
AR226-3211
|
XO1OvBOYOkpjvoov2ZkXkzXby |
40 |
|
The document is a certification report for a biopersistence screening study of an unspecified perfluorinated compound conducted by DuPont, detailing the methodology and findings from a 10-dose oral gavage study in rats.
|
2000 |
AR226-3216
|
0LaGD59MMzJzXME6m5vaqq3NV |
40 |
|
This is a DuPont analytical report (Supplement No. 1 for Study H-24159) detailing a biopersistence screening 10-dose oral gavage study in rats, completed on January 11, 2002.
|
2000 |
AR226-3217
|
oDVK41DX3kJ6JmX5bBe7248JE |
40 |
|
The document is a confidential report from DuPont Specialty Chemicals regarding an acute oral toxicity study of a perfluorinated compound conducted at Huntingdon Life Sciences, with a request for review and comments on the final draft.
|
1999 |
AR226-3109
|
MJ0En5bpZZwZMdMpdk3JarYex |
17 |
|
This document is a final drift report for a mouse micronucleus test conducted by Huntingdon Life Sciences for DuPont Specialty Chemicals, focusing on compliance with Good Laboratory Practice standards and awaiting quality assurance audit before issuing the final report.
|
1999 |
AR226-3110
|
kDqpzqr7j1Xk34QdGmXYZ4M0b |
25 |
|
The document reports on a skin irritation test conducted by DuPont on substances identified as H-23773 and H-23775, which were stable under study conditions, with the study completed on February 19, 1999.
|
1999 |
AR226-3114
|
k9rxEz4rVqE6dre6VQRbVBR5D |
12 |
|
This document is a study report from DuPont detailing the Local Lymph Node Assay (LLNA) for evaluating the potential skin sensitization of a trade secret substance, with the study completed on April 7, 1999.
|
1999 |
AR226-3119
|
pgBYok5ezD171KxZyXpLkLdD |
11 |
|
The document is a study report by DuPont on a skin irritation test conducted on rabbits using a trade secret substance, with the study completed on July 30, 1999.
|
1999 |
AR226-3128
|
3Jp10dd8pkQdYdKG7bRxY9gBJ |
12 |
|
The document reports on an eye irritation test conducted by DuPont on a test substance, evaluating its acute eye irritation potential in rabbits, with no evidence of instability observed during the study.
|
1999 |
AR226-3130
|
aDVQYJo12ZbKL966ZJzLX55Mb |
12 |
|
This document is a certification report for a Local Lymph Node Assay (LLNA) study conducted by DuPont, evaluating the immunotoxicological effects of a substance, with the study completed on August 10, 1999, by Dr. Gregory S. Ladies.
|
1999 |
AR226-3129
|
6wjZgjLjxxJVppo88Lwqg9QY1 |
13 |
|
The document is a confidential report from DuPont Specialty Chemicals detailing a skin sensitization study on a test substance using the Magnusson & Kligman method, conducted by Huntingdon Life Sciences, with results and compliance with good laboratory practice standards included.
|
1999 |
AR226-3127
|
RjmdYg8yeK4VKqwZ5vee1pNwv |
25 |
|
The document reports on a study (H-24119) conducted by E. I. du Pont de Nemours and Company to determine the oral approximate lethal dose (ALD) of a test substance in male rats, indicating that the substance was stable under study conditions.
|
1999 |
AR226-3131
|
4v0zkE1j84722OdDwBJvxq2qN |
8 |
|
This is a study report (H-24256) from E. I. du Pont de Nemours and Company detailing a Local Lymph Node Assay (LLNA) conducted by Gregory S. Ladies, Ph.D., completed on November 15, 1999.
|
1999 |
AR226-3135
|
byL5XLNQY387MVNBYadQbyxV1 |
13 |
|
The document reports on a skin irritation test conducted by DuPont on rabbits using a trade secret substance, evaluating its potential irritative effects.
|
1999 |
AR226-3136
|
NX5KQM7qe9RQ782Rwvmb0xZb |
12 |
|
This document is a confidential skin sensitization study report conducted by Elf Atochem S.A. on a test substance, detailing the methodology and results of the study performed on guinea pigs to assess allergenicity.
|
1999 |
AR226-3134
|
OJ3k8dM8VOv7G5paM13KYNQyX |
33 |
|
The document reports on an eye irritation test conducted by E. I. du Pont de Nemours and Company on a test substance (identified as DuPont-3615) in rabbits, which was completed on December 9, 1999.
|
1999 |
AR226-3138
|
QkBkvMdK5Z9Bygk4MkOkw5q7k |
12 |
|
The document is a confidential report from Elf Atochem S.A. detailing an acute eye irritation study conducted on rabbits using a test substance, with results and evaluations of ocular reactions summarized by the study director, Xavier Manciaux.
|
1999 |
AR226-3137
|
Rp6y11dxz6vqxgw0Z3RBDD47n |
21 |
|
The document is a confidential report from Elf Atochem S.A. detailing an acute oral toxicity study of a test substance in rats, conducted by the Centre International de Toxicologie, with a completion date of December 13, 1999.
|
1999 |
AR226-3139
|
ymLdjjyjv2wbg4V8avnjy0XDn |
24 |
|
The document is a confidential report from Elf Atochem SA detailing an acute dermal irritation study conducted on rabbits to evaluate the effects of a test substance, with the study completed on December 13, 1999, at the Centre International de Toxicologie in France.
|
1999 |
AR226-3140
|
3Q29yJ7z319B9LgOZgDkQjgOa |
24 |
|
The document is a confidential report from Elf Atochem S.A. detailing an acute oral toxicity study of a test substance, likely related to perfluorinated compounds, conducted by the Centre International de Toxicologie, with findings on clinical signs, mortality, and body weight changes in treated rats.
|
1999 |
AR226-3141
|
xzd7JOO7kqo10OMybjyRe8kNE |
24 |
|
The document reports on a study conducted by DuPont evaluating the oral approximate lethal dose (ALD) of a test substance (H-24256) in male rats, finding that the ALD is greater than 11,000 mg/kg with no observed mortality or clinical signs of toxicity.
|
1999 |
AR226-3143
|
2JzyLR85Da8NeKdQmoZLxXaZN |
7 |
|
The document is a confidential study report conducted by Elf Atochem S.A. on the acute dermal irritation of a test substance in rabbits, completed on December 13, 1999, at the Centre International de Toxicologie, detailing the methodology and results of cutaneous examinations.
|
1999 |
AR226-3142
|
d07G3mwZ898RbxODjNLYz9gR |
22 |
|
This document is a toxicity study report by DuPont Specialty Chemicals on the oral administration of a test substance to CD rats for four weeks, conducted by Huntingdon Life Sciences Ltd. and compliant with Good Laboratory Practice standards.
|
1999 |
AR226-3132
|
xOVKyydD856pE10q8jgzj9B1 |
295 |
|
The document details a subchronic toxicity study conducted by E.I. du Pont de Nemours and Company, examining the effects of an unspecified test substance on rats over a 90-day period, in compliance with U.S. EPA Good Laboratory Practice Standards.
|
1998 |
AR226-3243
|
xda5KKd11351LDzwq6N2zwMmg |
215 |
|
This document is a final report of an acute dermal irritation/corrosion study conducted by WIL Research Laboratories on the substance H-22481 for E. I. du Pont de Nemours and Company, indicating compliance with Good Laboratory Practice standards despite a deviation in the characterization of the test substance.
|
1998 |
AR226-3086
|
g2Q43z2QOgJyVdK45x2ZdjZE3 |
38 |
|
The document is a final report of an acute dermal irritation/corrosion study conducted by WIL Research Laboratories for E. I. du Pont de Nemours and Company on the substance H-22482, which was performed in compliance with Good Laboratory Practice standards, noting a deviation in characterization that did not affect the study's validity.
|
1998 |
AR226-3087
|
6bMBZ9JRR8BLva6D8yK2833j4 |
38 |
|
The document reports on an eye irritation test conducted by E. I. du Pont de Nemours and Company using a test substance (identified as H-23004) on New Zealand White rabbits, indicating that the substance appeared stable during the study.
|
1998 |
AR226-3088
|
wDMJw8jLG22NYK7qZRJ5dR53V |
10 |
|
This document reports on a static acute 48-hour screening test conducted by DuPont to assess the aquatic toxicity of a perfluorinated compound, indicating that the 48-hour EC50 for Daphnia magna was between 50 and 500 mg/L, with 100% immobilization observed at 5000 mg/L.
|
1998 |
AR226-3089
|
OEy1ok2dZoRB8wKBQOG5BbbD1 |
2 |
|
The document reports that DuPont's H-23005 exhibited slight toxicity in a 96-hour static acute test using fathead minnows (Pimephales promelas) at various concentrations, indicating potential environmental impacts of the substance.
|
1998 |
AR226-3090
|
pmxnRK3bdxV1R35xpVGRQkMMw |
2 |
|
The document reports on a toxicity study conducted by DuPont on PFOA at various concentrations, indicating that exposure resulted in total mortality and slight toxicity at the highest tested levels.
|
1998 |
AR226-3091
|
omoZrqxO2ngrb41XYoVpnaVmg |
2 |
|
The document reports that DuPont's H-22762 exhibited slight toxicity in a 48-hour static acute test using Daphnia magna, indicating potential environmental impacts of the substance.
|
1998 |
AR226-3092
|
Lp139VK3km5vE3onwvzqOKayb |
2 |
|
The document is a Bacterial Reverse Mutation Test study conducted by E. I. du Pont de Nemours and Company, which assessed the mutagenic potential of a test substance related to PFOA, confirming compliance with Good Laboratory Practice standards despite minor deviations.
|
1998 |
AR226-3093
|
k6VLqyMzak9gpVnD57y4VboV |
31 |
|
The document is a final report of an in vitro mammalian cell gene mutation test conducted by E. I. du Pont de Nemours and Company, assessing the mutagenic potential of a substance under Good Laboratory Practice standards, with a noted exception regarding the analysis of treatment solutions that did not affect the study's validity.
|
1998 |
AR226-3094
|
zKVYjeG4Ey6zp9mwO84jjNEm |
31 |
|
The document is a study report from Atochem S.A. detailing the acute oral toxicity of a test substance in rats, conducted by the Centre International de Toxicologie, with a completion date of May 14, 1998.
|
1998 |
AR226-3096
|
np8Mk95JnE3L993yM6X5ydxpm |
23 |
|
The document reports on a study conducted by ConTox Ltd. for E. I. Du Pont de Nemours and Company, which found that the test materials H-23004 and H-23045, along with the control H-23046, did not cause adverse skin responses in a 100-person human patch test, indicating they are not skin irritants or sensitizing agents.
|
1998 |
AR226-3095
|
5bzZqvZqz53KXEEj31qK4QMJ5 |
33 |
|
The document reports on a skin irritation test conducted by E. I. du Pont de Nemours and Company on the substance DuPont-1139, indicating that the test substance appeared stable and showed no evidence of instability during the study.
|
1998 |
AR226-3099
|
DDexdQObEGK9BKYOYYY5v5E1d |
12 |
|
The document reports on an acute dermal irritation study conducted by Elf Atochem S.A. using a test substance on rabbits, completed on May 20, 1998, and adheres to Good Laboratory Practice principles.
|
1998 |
AR226-3098
|
pm29ZwMREokkXrDzqx79mzmrX |
20 |
|
The document reports on a skin irritation test conducted by E. I. du Pont de Nemours and Company on a test substance, evaluating its acute skin irritation potential in rabbits, with no evidence of instability observed during the study.
|
1998 |
AR226-3100
|
bqZdyEypvYgkDr6qZn4V88M1 |
10 |
|
This document is a TNO report detailing an acute inhalation toxicity study of an unspecified perfluorinated compound conducted on rats at the request of ELF Atochem S.A., with findings related to the effects of a 4-hour exposure period.
|
1998 |
AR226-3104
|
ZJadnnjN0k55zQj4vjBRkGjLO |
58 |
|
The document reports on an augmented acute inhalation toxicity study of two different batches of a substance, likely related to PFOA or PFOS, conducted by TNO Nutrition and Food Research Institute, where rats were exposed to limit concentrations for a single 4-hour period and subsequently necropsied for analysis.
|
1998 |
AR226-3105
|
gaKxNgEXqe8yRwQ5Y6ypeabXa |
81 |
|
The document reports on a bacterial reverse mutation test conducted by DuPont on perfluorinated compounds, specifically assessing the mutagenic potential of a test substance using Salmonella typhimurium and Escherichia coli, in compliance with U.S. EPA Good Laboratory Practice Standards.
|
1998 |
AR226-3126
|
3e0kMmydN2DJLK23MBwmgY8Va |
24 |
|
This document reports on a bacterial reverse mutation test conducted by DuPont Pharmaceuticals Company to evaluate the mutagenic potential of a substance, following U.S. EPA and OECD guidelines.
|
1998 |
AR226-3151
|
mq6XrVRVKQpJ8dd6d335b5BKd |
25 |
|
This document reports on a bacterial reverse mutation test conducted by DuPont Pharmaceuticals to evaluate the mutagenic potential of a substance, following U.S. EPA and OECD guidelines.
|
1998 |
AR226-3153
|
YjqRVXm5YOpJBM46EBYzxKEEy |
25 |
|
This document reports on a bacterial reverse mutation test conducted by DuPont Pharmaceuticals to evaluate the mutagenic potential of a substance, following U.S. EPA and OECD guidelines.
|
1998 |
AR226-3154
|
b5jxaERaEanDJyrXv1Epd6896 |
25 |
|
The document details a bacterial reverse mutation test (Study No. AA47TV.502001.BTL) conducted by Bio Reliance for E. I. du Pont de Nemours and Company, which complies with various GLP regulations but notes that the identity, stability, and concentration of the test substances were not determined.
|
1998 |
AR226-3189
|
995ZEYB30v1g1E0n0yaDnjxK6 |
62 |
|
This document details a subchronic toxicity 90-day gavage study in rats conducted by E.I. du Pont de Nemours and Company, evaluating a trade secret test substance, likely related to PFOA or PFOS, under U.S. EPA Good Laboratory Practice Standards.
|
1998 |
AR226-3184
|
przL18bn547x5w6JDj8mLgXa |
295 |